These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7872812)

  • 1. [Anatomopathological problems of mastopathies at risk].
    Contesso G; Mathieu MC; Guinebretière JM; Zemoura L; Bertin F; Petit JY; Lê M
    Arch Anat Cytol Pathol; 1994; 42(5):211-6. PubMed ID: 7872812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diseases of the female breast: clinical pathology].
    Torhorst J
    Ther Umsch; 1993 May; 50(5):307-13. PubMed ID: 8397447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic analysis of breast lesions associated with multiple papillomas.
    Ali-Fehmi R; Carolin K; Wallis T; Visscher DW
    Hum Pathol; 2003 Mar; 34(3):234-9. PubMed ID: 12673557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In situ proliferative epithelial lesions of the breast.
    Kamel OW; Kempson RL; Hendrickson MR
    Pathology (Phila); 1992; 1(1):65-102. PubMed ID: 9420916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beyond fibrocystic disease. The evolving concept of pre-malignant breast disease.
    Shirley SE
    West Indian Med J; 1999 Dec; 48(4):173-8. PubMed ID: 10639833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Breast diseases (fibroadenomas, mastopathies, breast cancers) in hormonal contraception].
    Nizze H; Kändler U
    Zentralbl Gynakol; 1988; 110(20):1296-302. PubMed ID: 3239299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucinous breast lesions: diagnostic challenges.
    Tan PH; Tse GM; Bay BH
    J Clin Pathol; 2008 Jan; 61(1):11-9. PubMed ID: 17873114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types.
    Marshall LM; Hunter DJ; Connolly JL; Schnitt SJ; Byrne C; London SJ; Colditz GA
    Cancer Epidemiol Biomarkers Prev; 1997 May; 6(5):297-301. PubMed ID: 9149887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Papillary apocrine change of the breast: associations with atypical hyperplasia and risk of breast cancer.
    Page DL; Dupont WD; Jensen RA
    Cancer Epidemiol Biomarkers Prev; 1996 Jan; 5(1):29-32. PubMed ID: 8770463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnostic immunohistochemistry of breast epithelial lesions].
    Balaton AJ; Guinebretière JM; Penault-Llorca F
    Ann Pathol; 2003 Dec; 23(6):570-81. PubMed ID: 15094595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Management of ductal carcinoma in situ by the pathologist: current questions].
    Arnould L; Caron Y; Sigal-Zafrani B
    Ann Pathol; 2003 Dec; 23(6):534-46. PubMed ID: 15094591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New aspects in the histological diagnosis of breast carcinoma.
    Shousha S
    Semin Surg Oncol; 1996; 12(1):12-25. PubMed ID: 8821405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ductal lavage and risk assessment of breast cancer.
    Arun B
    Oncologist; 2004; 9(6):599-605. PubMed ID: 15561804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fibrocystic mastopathy and cancer of the breast. About 111 cases].
    Beyrouti MI; Beyrouti R; Khabir A; Ben Amar M; Frikha F; Dhieb N; Damak D; Abid M; Affes N; Boujelben S; Frikha M
    Tunis Med; 2006 Oct; 84(10):626-31. PubMed ID: 17193854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interobserver reproducibility in the pathologic diagnosis of borderline ductal proliferative breast diseases].
    Wei B; Bu H; Zhu CR; Guo LX; Chen HJ; Zhao C; Zhang P; Chen DY; Tang Y; Jiang Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Nov; 35(6):849-53. PubMed ID: 15573772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrocystic change and fibrocystic disease of the breast.
    Drukker BH; deMendonca WC
    Obstet Gynecol Clin North Am; 1987 Sep; 14(3):685-702. PubMed ID: 3323971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triad of columnar cell alteration, lobular carcinoma in situ, and tubular carcinoma of the breast.
    Sahoo S; Recant WM
    Breast J; 2005; 11(2):140-2. PubMed ID: 15730461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lobular carcinoma in situ diagnosed by core needle biopsy: when should it be excised?
    Middleton LP; Grant S; Stephens T; Stelling CB; Sneige N; Sahin AA
    Mod Pathol; 2003 Feb; 16(2):120-9. PubMed ID: 12591964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hyperplastic lesions of the high risk breast. Definitions, diagnostic and therapeutic problems].
    Scali P; Contesso G
    J Gynecol Obstet Biol Reprod (Paris); 1992; 21(2):155-62. PubMed ID: 1583292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Benign and premalignant breast lesions--clinico-pathological correlation].
    Afek A; Shibi R; Kopolovitz G
    Harefuah; 1997 Nov; 133(9):375-8. PubMed ID: 9418343
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.